Destruction of conditional insulinoma cell lines in NOD mice: A role for autoimmunity

Diabetologia

Volumn 46, Issue 4, 2003, Pages 504-510

  Cattan, P ^a   Rottembourg, D ^a   Cottet, S ^b   Tardivel, I ^a   Dupraz, P ^b   Thorens, B ^b   Boitard, C ^a   Carel, J C ^a  

^a Grp Hosp Cochin S Vincent de Paul ^*  (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Autoimmunity; Bcl 2; MyD88; NOD mice; NOD scid; SOCS 1; Streptozotocin; TC tet cell line

Indexed keywords

ADAPTOR PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BCL 2; STREPTOZOCIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENETIC ENGINEERING; GRAFT REJECTION; HISTOPATHOLOGY; HYBRIDOMA CELL CULTURE; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL; STREPTOZOCIN DIABETES; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0038293346     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1062-3     Document Type: Article

References (17)

1. Efrat S, Fusco-De Mane D, Lemberg H, al Emran O, Wang X (1995) Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 92:3576-3580
2. Dupraz P, Rinsch C, Pralong WF et al. (1999) Lentivirus-mediated Bcl-2 expression in BTC-Tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther 6:1160-1169
3. Pericin M, Althage A, Freigang S et al. (2002) Allogeneic beta-islet cells correct diabetes and resist immune rejection. Proc Natl Acad Sci USA 99:8203-8206
4. Dupraz P, Cottet S, Hamburger F, Dolci W, Felley-Bosco E, Thorens B (2000) Dominant negative MyD88 proteins inhibit interleukin-1beta/interferon-gamma-mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells. J Biol Chem 275:37672-37578
5. Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B (2001) SOCS-1 protein prevents janus kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma. J Biol Chem 276:25862-25870
6. Hartemann AH, Richard MF, Boitard C (1999) Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice. Clin Exp Immunol 116:225-230
7. Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K (1988) T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444-1448
8. Halbout P, Briand JP, Bécourt C, Muller S, Boitard C (2002) T cell response to preproinsulin 1 and 2 in the NOD mouse. J Immunol 169:2436-2443
9. Ricordi C, Lacy PE (1987) Renal subcapsular xenotrans-plantation of purified porcine islets. Transplantation 44:721-723
10. McEvoy RC, Andersson J, Sandler S, Hellerstrom C (1984) Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J Clin Invest 74:715-722
11. Delovitch TL, Singh B (1997) The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727-738
12. Iwahashi H, Hanafusa T, Eguchi Y et al. (1996) Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia 39:530-536
13. Rabinovitch A, Suarez-Pinzon W, Strynadka K et al. (1999) Transfection of human pancreatic islets with an anti-apoptotic gene (Bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48:1223-1229
14. Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C (1999) A20 inhibits cytokine-induced apoptosis and nuclear factor KappaB-dependent gene activation in islets. J Exp Med 190:1135-1146
15. Giannoukakis N, Rudert WA, Ghivizzani et al. (1999) Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 48:1730-1736
16. Allison J, Thomas H, Beck D et al. (2000) Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. Int Immunol 12:9-17
17. Giannoukakis N, Rudert WA, Robbins PD, Trucco M (1999) Targeting autoimmune diabetes with gene therapy. Diabetes 48:2107-2121